Every Form 4 that Glimpse Group Inc (The) (GGRP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow GGRP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GGRP filings page.
Glimpse Group, Inc. director Tamar Elkeles received a grant of stock options covering 174,368 shares of common stock on July 10, 2026, with an exercise price of $0.77 per share and expiration on July 10, 2036. The grant vests in equal monthly installments over one year from the grant date. Elkeles also holds earlier option grants for 145,000, 37,500 and 20,000 shares at exercise prices of $0.69, $2.25 and $2.50, expiring between 2034 and 2036, some of which are already fully vested.
Glimpse Group, Inc. director Brian Archer received a grant of stock options covering 283,012 shares of common stock on July 10, 2026. The options have a $0.77 exercise price, expire on July 10, 2036, and vest in equal monthly installments over one year. After this grant, Archer directly holds these options, a warrant over 75,000 shares at a $0.55 exercise price, and 60,000 shares of common stock.
Glimpse Group, Inc. director Swift Scott Harbison received a grant of stock options for 307,759 shares of common stock on July 10, 2026, at an exercise price of $0.7700 per share, vesting in equal monthly installments over one year and expiring July 10, 2036.
After this grant, he directly holds these options plus warrants covering 25,000 shares at $0.5500 per share, expiring November 18, 2033, and 20,000 shares of common stock.
Glimpse Group, Inc. director Peter M. Fesler received a grant of stock options covering 174,368 shares of common stock on July 10, 2026. The options have an exercise price of $0.77 per share, expire on July 10, 2036, and vest in equal monthly installments over one year.
Glimpse Group, Inc. reported that former director Alexander Ruckdaeschel received two stock option awards linked to the company’s common stock. On 1 January 2025, he was granted options for 37,500 shares with an exercise price of $2.25 per share, vesting in equal monthly increments from 31 January 2025 through 31 December 2025.
On 1 May 2026, he received an additional grant of options for 60,417 shares with an exercise price of $0.69 per share, which vested immediately upon grant. Both option series are scheduled to expire on 31 May 2031. The filing does not report any corresponding stock sales or exercises.
Charles Ian Morgan, a former director of Glimpse Group, Inc., received two stock option awards. On May 1, 2026 he was granted 60,417 stock options with a $0.6900 exercise price, expiring May 31, 2031, which vested immediately. On January 1, 2025 he was granted 37,500 stock options with a $2.2500 exercise price, also expiring May 31, 2031, vesting in equal monthly installments from January 31 through December 31, 2025. These transactions reflect option grants, with no reported share purchases or sales, and the Rule 10b5-1 trading plan box was not checked.
Glimpse Group, Inc. reported that former director Jeffrey D. Enslin, through Perimetre Capital, LLC, acquired two stock option awards. On May 1, 2026 he received 54,375 options with a $0.6900 exercise price that vested immediately. On January 1, 2025 he received 37,500 options with a $2.2500 exercise price, vesting in equal monthly increments from January 31, 2025 through December 31, 2025. Both awards are exercisable into common stock and expire on May 15, 2031.
Glimpse Group, Inc. reported that former director Amen Lemuel received a grant of stock options on 2025-01-01. The award covers 37,500 options to buy common stock at an exercise price of $2.25 per share, expiring on 2027-02-12.
According to the footnote, this option vests in equal monthly installments from 01/31/2025 through 12/31/2025. After the grant, Lemuel held options for 37,500 underlying shares, all reported as directly owned.
Glimpse Group, Inc. reported that director Tamar Elkeles received two stock option grants as equity compensation, not open-market trades. On January 1, 2025, Elkeles was granted options for 37,500 shares of common stock at an exercise price of $2.25 per share, vesting in equal monthly increments from January 31, 2025 through December 31, 2025, and expiring on January 1, 2035.
On May 1, 2026, Elkeles was granted additional options for 145,000 shares at an exercise price of $0.69 per share, expiring on May 1, 2036. These options vest with respect to 60,422 shares on May 31, 2026, with the remaining portion vesting in equal monthly increments from June 30, 2026 through December 31, 2026. Following these grants, the filings show option holdings of 37,500 and 145,000 shares for the respective awards.
Glimpse Group, Inc. reported that President and CEO Tyler Gates received equity-based compensation. He was granted 36,364 shares of common stock at $0.55 per share, bringing his direct holdings to 143,507 shares.
He was also granted a warrant covering 45,455 shares of common stock at an exercise price of $0.55 per share. The warrant becomes exercisable on November 18, 2026 and expires on November 18, 2033. These are awards from the company, not open-market purchases or sales.
Glimpse Group, Inc. insider Bentovim Lyron L, who serves as President and CEO, submitted a Form 4 reporting his position in company securities. The available data show no reported purchases, sales, option exercises, gifts, or other insider transactions during the covered period.